vs
AtriCure, Inc.（ATRC）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是AtriCure, Inc.的1.6倍（$225.0M vs $140.5M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 13.1%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $18.4M），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs -12.3%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
ATRC vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.6倍
$140.5M
营收增速更快
ROCK
高出11.9%
13.1%
自由现金流更多
ROCK
多$7.8M
$18.4M
两年增速更快
ATRC
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $225.0M |
| 净利润 | — | — |
| 毛利率 | 75.0% | 25.3% |
| 营业利润率 | 1.8% | 7.9% |
| 净利率 | — | — |
| 营收同比 | 13.1% | 24.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.04 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCROCK
| Q4 25 | $140.5M | $225.0M | ||
| Q3 25 | $134.3M | $310.9M | ||
| Q2 25 | $136.1M | $309.5M | ||
| Q1 25 | $123.6M | $290.0M | ||
| Q4 24 | $124.3M | $180.1M | ||
| Q3 24 | $115.9M | $277.1M | ||
| Q2 24 | $116.3M | $273.6M | ||
| Q1 24 | $108.9M | $292.5M |
净利润ATRCROCK
| Q4 25 | — | — | ||
| Q3 25 | $-267.0K | $-89.1M | ||
| Q2 25 | $-6.2M | $26.0M | ||
| Q1 25 | $-6.7M | $21.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.9M | $34.0M | ||
| Q2 24 | $-8.0M | $32.2M | ||
| Q1 24 | $-13.3M | $24.9M |
毛利率ATRCROCK
| Q4 25 | 75.0% | 25.3% | ||
| Q3 25 | 75.5% | 26.6% | ||
| Q2 25 | 74.5% | 28.4% | ||
| Q1 25 | 74.9% | 26.8% | ||
| Q4 24 | 74.5% | 29.0% | ||
| Q3 24 | 74.9% | 29.4% | ||
| Q2 24 | 74.7% | 30.5% | ||
| Q1 24 | 74.7% | 28.9% |
营业利润率ATRCROCK
| Q4 25 | 1.8% | 7.9% | ||
| Q3 25 | 0.2% | 12.8% | ||
| Q2 25 | -4.5% | 12.8% | ||
| Q1 25 | -4.8% | 8.8% | ||
| Q4 24 | -11.7% | 13.3% | ||
| Q3 24 | -6.4% | 15.6% | ||
| Q2 24 | -6.2% | 14.9% | ||
| Q1 24 | -10.0% | 10.8% |
净利率ATRCROCK
| Q4 25 | — | — | ||
| Q3 25 | -0.2% | -28.6% | ||
| Q2 25 | -4.5% | 8.4% | ||
| Q1 25 | -5.5% | 7.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.8% | 12.3% | ||
| Q2 24 | -6.9% | 11.8% | ||
| Q1 24 | -12.2% | 8.5% |
每股收益（稀释后）ATRCROCK
| Q4 25 | $0.04 | — | ||
| Q3 25 | $-0.01 | $-2.98 | ||
| Q2 25 | $-0.13 | $0.87 | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-0.33 | — | ||
| Q3 24 | $-0.17 | $1.11 | ||
| Q2 24 | $-0.17 | $1.05 | ||
| Q1 24 | $-0.28 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $491.9M | $950.4M |
| 总资产 | $654.2M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ATRCROCK
| Q4 25 | $167.4M | $115.7M | ||
| Q3 25 | $147.9M | $89.4M | ||
| Q2 25 | $117.8M | $43.3M | ||
| Q1 25 | $99.9M | $25.1M | ||
| Q4 24 | $122.7M | $269.5M | ||
| Q3 24 | $130.3M | $228.9M | ||
| Q2 24 | $114.0M | $179.1M | ||
| Q1 24 | $106.0M | $146.7M |
总债务ATRCROCK
| Q4 25 | — | $0 | ||
| Q3 25 | $61.9M | $0 | ||
| Q2 25 | $61.9M | $0 | ||
| Q1 25 | $61.9M | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $61.9M | $0 | ||
| Q2 24 | $61.9M | $0 | ||
| Q1 24 | $61.9M | $0 |
股东权益ATRCROCK
| Q4 25 | $491.9M | $950.4M | ||
| Q3 25 | $476.5M | $951.8M | ||
| Q2 25 | $464.5M | $1.0B | ||
| Q1 25 | $454.6M | $1.0B | ||
| Q4 24 | $461.0M | $1.0B | ||
| Q3 24 | $465.0M | $1.0B | ||
| Q2 24 | $462.1M | $975.7M | ||
| Q1 24 | $456.3M | $940.2M |
总资产ATRCROCK
| Q4 25 | $654.2M | $1.4B | ||
| Q3 25 | $635.4M | $1.4B | ||
| Q2 25 | $608.8M | $1.5B | ||
| Q1 25 | $591.6M | $1.4B | ||
| Q4 24 | $609.3M | $1.4B | ||
| Q3 24 | $615.1M | $1.4B | ||
| Q2 24 | $597.3M | $1.4B | ||
| Q1 24 | $591.6M | $1.3B |
负债/权益比ATRCROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | 0.13× | 0.00× | ||
| Q2 25 | 0.13× | 0.00× | ||
| Q1 25 | 0.14× | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.13× | 0.00× | ||
| Q2 24 | 0.13× | 0.00× | ||
| Q1 24 | 0.14× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $26.2M |
| 自由现金流率自由现金流/营收 | 13.1% | 11.7% |
| 资本支出强度资本支出/营收 | 1.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $48.3M | $120.6M |
8季度趋势，按日历期对齐
经营现金流ATRCROCK
| Q4 25 | $20.0M | $35.5M | ||
| Q3 25 | $26.7M | $73.0M | ||
| Q2 25 | $21.6M | $44.9M | ||
| Q1 25 | $-11.0M | $13.7M | ||
| Q4 24 | $5.8M | $19.9M | ||
| Q3 24 | $20.0M | $64.7M | ||
| Q2 24 | $7.4M | $36.5M | ||
| Q1 24 | $-21.0M | $53.2M |
自由现金流ATRCROCK
| Q4 25 | $18.4M | $26.2M | ||
| Q3 25 | $24.1M | $64.8M | ||
| Q2 25 | $19.0M | $27.3M | ||
| Q1 25 | $-13.2M | $2.3M | ||
| Q4 24 | $3.1M | $14.1M | ||
| Q3 24 | $16.4M | $60.5M | ||
| Q2 24 | $5.0M | $33.5M | ||
| Q1 24 | $-23.8M | $48.8M |
自由现金流率ATRCROCK
| Q4 25 | 13.1% | 11.7% | ||
| Q3 25 | 18.0% | 20.8% | ||
| Q2 25 | 13.9% | 8.8% | ||
| Q1 25 | -10.7% | 0.8% | ||
| Q4 24 | 2.5% | 7.8% | ||
| Q3 24 | 14.1% | 21.8% | ||
| Q2 24 | 4.3% | 12.2% | ||
| Q1 24 | -21.9% | 16.7% |
资本支出强度ATRCROCK
| Q4 25 | 1.1% | 4.1% | ||
| Q3 25 | 1.9% | 2.6% | ||
| Q2 25 | 2.0% | 5.7% | ||
| Q1 25 | 1.8% | 3.9% | ||
| Q4 24 | 2.2% | 3.3% | ||
| Q3 24 | 3.1% | 1.5% | ||
| Q2 24 | 2.1% | 1.1% | ||
| Q1 24 | 2.5% | 1.5% |
现金转化率ATRCROCK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
